Inspire Medical Systems Files 8-K on Financials
Ticker: INSP · Form: 8-K · Filed: Jul 29, 2024 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Inspire Medical Systems dropped an 8-K detailing their latest financial results.
AI Summary
Inspire Medical Systems, Inc. filed an 8-K on July 29, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides investors with crucial updates on Inspire Medical Systems' financial performance and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate material risks.
Key Players & Entities
- Inspire Medical Systems, Inc. (company) — Registrant
- July 29, 2024 (date) — Date of report
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
What is the exact date of this filing?
The exact date of this filing is July 29, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota 55416.
What is the company's telephone number?
The company's telephone number is (844) 672-4357.
What is the Standard Industrial Classification code for Inspire Medical Systems, Inc.?
The Standard Industrial Classification code for Inspire Medical Systems, Inc. is 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
Filing Stats: 549 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-07-29 06:46:37
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share INSP New York Stock
Filing Documents
- insp-20240729.htm (8-K) — 27KB
- insp2024-q2prereleaseex991.htm (EX-99.1) — 14KB
- inspirelogo.jpg (GRAPHIC) — 14KB
- 0001609550-24-000034.txt ( ) — 189KB
- insp-20240729.xsd (EX-101.SCH) — 2KB
- insp-20240729_lab.xml (EX-101.LAB) — 22KB
- insp-20240729_pre.xml (EX-101.PRE) — 13KB
- insp-20240729_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On July 29, 2024, Inspire Medical Systems, Inc. (the "Company") issued a press release announcing certain preliminary and unaudited results for the quarter ended June 30, 2024. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in Item 2.02 of this Current Report on Form 8-K ("Form 8-K") (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Inspire Medical Systems, Inc., dated July 29 , 202 4 . 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: July 29, 2024 By: /s/ Richard J. Buchholz Richard J. Buchholz Chief Financial Officer 3